Berylson Capital Partners, LLC / MRNA
Berylson Capital Partners, LLC’s Moderna Inc Position
Does Berylson Capital Partners, LLC own Moderna Inc (MRNA)? Not currently — the last reported position was 52.4K shares worth $3M in Q2 2020; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$3M
Q2 2020
Shares
52.4K
% of Portfolio
+2.07%
Quarters Held
1
position exited
Position History MRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2020 | 52.4K | $3M | +2.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Berylson Capital Partners, LLC’s full portfolio or all institutional holders of MRNA.